Nevertheless, other research demonstrated that the levels of serum anti-LAMP-2 antibody were similar in ANCA-associated vasculitis (AAV) patients compared to healthy controls (HC) [22, 23, 25]. This evidence concerns the gene LAMP2 and anti-neutrophil cytoplasmic antibody-associated vasculitis.